CO4900055A1 - 3,4-di-indolil pirroles - Google Patents
3,4-di-indolil pirrolesInfo
- Publication number
- CO4900055A1 CO4900055A1 CO97042581A CO97042581A CO4900055A1 CO 4900055 A1 CO4900055 A1 CO 4900055A1 CO 97042581 A CO97042581 A CO 97042581A CO 97042581 A CO97042581 A CO 97042581A CO 4900055 A1 CO4900055 A1 CO 4900055A1
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- aryl
- aralkyl
- hydrogen
- independently
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 229910052739 hydrogen Inorganic materials 0.000 abstract 7
- 125000003118 aryl group Chemical group 0.000 abstract 6
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 150000002431 hydrogen Chemical class 0.000 abstract 4
- 150000007513 acids Chemical class 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004442 acylamino group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 150000007514 bases Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- -1 nitro , amino Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2207996P | 1996-07-29 | 1996-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4900055A1 true CO4900055A1 (es) | 2000-03-27 |
Family
ID=21807711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO97042581A CO4900055A1 (es) | 1996-07-29 | 1997-07-25 | 3,4-di-indolil pirroles |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US5856517A (OSRAM) |
| EP (1) | EP0915872B1 (OSRAM) |
| JP (1) | JP2000516589A (OSRAM) |
| KR (1) | KR20000029637A (OSRAM) |
| CN (2) | CN1495182A (OSRAM) |
| AR (1) | AR008267A1 (OSRAM) |
| AT (1) | ATE240318T1 (OSRAM) |
| AU (1) | AU739742B2 (OSRAM) |
| BR (1) | BR9711605A (OSRAM) |
| CA (1) | CA2262092A1 (OSRAM) |
| CO (1) | CO4900055A1 (OSRAM) |
| CY (1) | CY2483B1 (OSRAM) |
| DE (1) | DE69722003T2 (OSRAM) |
| DK (1) | DK0915872T3 (OSRAM) |
| ES (1) | ES2198001T3 (OSRAM) |
| HR (1) | HRP970414A2 (OSRAM) |
| MA (1) | MA24287A1 (OSRAM) |
| PE (1) | PE91698A1 (OSRAM) |
| PT (1) | PT915872E (OSRAM) |
| SA (1) | SA97180473A (OSRAM) |
| TR (1) | TR199900157T2 (OSRAM) |
| WO (1) | WO1998004552A1 (OSRAM) |
| ZA (1) | ZA976492B (OSRAM) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE243693T1 (de) * | 1998-03-17 | 2003-07-15 | Hoffmann La Roche | Substituierte bisindolylmaleimide zur inhibierung der zellproliferation |
| WO2001044235A2 (en) * | 1999-12-16 | 2001-06-21 | Eli Lilly And Company | Agents and methods for the treatment of proliferative diseases |
| EP1242420A2 (en) | 1999-12-16 | 2002-09-25 | Eli Lilly And Company | Agents and methods for the treatment of proliferative diseases |
| US6313143B1 (en) * | 1999-12-16 | 2001-11-06 | Hoffmann-La Roche Inc. | Substituted pyrroles |
| US6743785B2 (en) * | 1999-12-16 | 2004-06-01 | Eli Lilly And Company | Agents and methods for the treatment of proliferative diseases |
| US6281356B1 (en) | 1999-12-22 | 2001-08-28 | Hoffmann-La Roche Inc. | Substituted pyrroles |
| TW201041580A (en) | 2001-09-27 | 2010-12-01 | Alcon Inc | Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
| US20030139373A1 (en) * | 2001-11-20 | 2003-07-24 | Breimer Lars Holger | Method for cancer therapy |
| MY142390A (en) * | 2002-05-22 | 2010-11-30 | Glaxosmithkline Llc | 3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| US7012100B1 (en) * | 2002-06-04 | 2006-03-14 | Avolix Pharmaceuticals, Inc. | Cell migration inhibiting compositions and methods and compositions for treating cancer |
| DK1846406T5 (da) | 2005-02-09 | 2011-10-31 | Arqule Inc | Maleimidderivater, farmaceutiske sammensætninger og fremgangsmåder til behandling af cancer |
| BRPI0720388A2 (pt) * | 2006-12-19 | 2014-01-14 | Novartis Ag | Derivados de indolilmaleimida |
| JP5425060B2 (ja) | 2007-06-22 | 2014-02-26 | アークル インコーポレイテッド | ピロリジノン、ピロリジン−２，５−ジオン、ピロリジンおよびチオスクシンイミド誘導体、癌の治療のための組成物および方法 |
| BRPI0813355A2 (pt) | 2007-06-22 | 2014-12-30 | Arqule Inc | Compostos de quinazolinona e métodos de uso dos mesmos |
| US8513292B2 (en) | 2007-06-22 | 2013-08-20 | Arqule, Inc. | Compositions and methods for the treatment of cancer |
| JP2009035537A (ja) * | 2007-07-10 | 2009-02-19 | Nippon Synthetic Chem Ind Co Ltd:The | Ｎ−置換アニリン誘導体及び１−置換インドール誘導体の製造方法 |
| FR2927075A1 (fr) * | 2008-02-04 | 2009-08-07 | Centre Nat Rech Scient | Molecules comprenant un squelette bis-(heteroaryl)maleimide, et leur utilisation dans l'inhibition d'enzymes |
| GB201111427D0 (en) * | 2011-07-05 | 2011-08-17 | Amakem Nv | Novel bisindolylmaleimides, pan-pkc inhibitors |
| CA2939219C (en) | 2014-02-11 | 2023-02-28 | Mitokinin Llc | Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease |
| US20170209488A1 (en) | 2014-07-17 | 2017-07-27 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for treating neuromuscular junction-related diseases |
| WO2016207366A1 (en) | 2015-06-26 | 2016-12-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of viral infections |
| KR20200019228A (ko) | 2017-06-21 | 2020-02-21 | 미토키닌, 인크. | 신경퇴행성 및 미토콘드리아 질환의 치료를 위한 조성물 및 이를 사용하는 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ280738B6 (cs) * | 1988-02-10 | 1996-04-17 | F. Hoffmann - La Roche And Co., Aktiengesellschaft | Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi |
| PT93947B (pt) * | 1989-05-05 | 1996-11-29 | Goedecke Ag | Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem |
| US5380746A (en) * | 1989-05-05 | 1995-01-10 | Goedecke Aktiengesellschaft | Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| DE4005969A1 (de) * | 1990-02-26 | 1991-08-29 | Boehringer Mannheim Gmbh | Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten |
| JPH0539289A (ja) * | 1991-02-15 | 1993-02-19 | Masahiro Irie | 無水マレイン酸誘導体およびその製造方法 |
| EP0630241A1 (en) * | 1992-03-20 | 1994-12-28 | The Wellcome Foundation Limited | Indole derivatives with antiviral activity |
| DE4217964A1 (de) * | 1992-05-30 | 1993-12-02 | Goedecke Ag | Indolocarbazol-Imide und deren Verwendung |
-
1997
- 1997-07-15 PE PE1997000630A patent/PE91698A1/es not_active Application Discontinuation
- 1997-07-19 AU AU37690/97A patent/AU739742B2/en not_active Ceased
- 1997-07-19 AT AT97934498T patent/ATE240318T1/de not_active IP Right Cessation
- 1997-07-19 ES ES97934498T patent/ES2198001T3/es not_active Expired - Lifetime
- 1997-07-19 DK DK97934498T patent/DK0915872T3/da active
- 1997-07-19 EP EP97934498A patent/EP0915872B1/en not_active Expired - Lifetime
- 1997-07-19 KR KR1019997000706A patent/KR20000029637A/ko not_active Abandoned
- 1997-07-19 CN CNA031275400A patent/CN1495182A/zh active Pending
- 1997-07-19 TR TR1999/00157T patent/TR199900157T2/xx unknown
- 1997-07-19 WO PCT/EP1997/003889 patent/WO1998004552A1/en not_active Ceased
- 1997-07-19 PT PT97934498T patent/PT915872E/pt unknown
- 1997-07-19 BR BR9711605A patent/BR9711605A/pt not_active Application Discontinuation
- 1997-07-19 JP JP10508453A patent/JP2000516589A/ja not_active Ceased
- 1997-07-19 DE DE69722003T patent/DE69722003T2/de not_active Expired - Fee Related
- 1997-07-19 CN CNB971967768A patent/CN1151149C/zh not_active Expired - Fee Related
- 1997-07-19 CA CA002262092A patent/CA2262092A1/en not_active Abandoned
- 1997-07-22 AR ARP970103309A patent/AR008267A1/es not_active Application Discontinuation
- 1997-07-22 ZA ZA9706492A patent/ZA976492B/xx unknown
- 1997-07-24 US US08/899,852 patent/US5856517A/en not_active Expired - Fee Related
- 1997-07-25 CO CO97042581A patent/CO4900055A1/es unknown
- 1997-07-25 HR HR60/022,079A patent/HRP970414A2/hr not_active Application Discontinuation
- 1997-07-29 MA MA24744A patent/MA24287A1/fr unknown
- 1997-10-06 SA SA97180473A patent/SA97180473A/ar unknown
-
1998
- 1998-10-05 US US09/166,766 patent/US6030994A/en not_active Expired - Fee Related
-
2004
- 2004-11-15 CY CY0400081A patent/CY2483B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0915872A1 (en) | 1999-05-19 |
| ATE240318T1 (de) | 2003-05-15 |
| SA97180473A (ar) | 2005-12-03 |
| PT915872E (pt) | 2003-09-30 |
| PE91698A1 (es) | 1998-12-24 |
| KR20000029637A (ko) | 2000-05-25 |
| HRP970414A2 (en) | 1998-06-30 |
| WO1998004552A1 (en) | 1998-02-05 |
| CN1226247A (zh) | 1999-08-18 |
| JP2000516589A (ja) | 2000-12-12 |
| CA2262092A1 (en) | 1998-02-05 |
| ES2198001T3 (es) | 2004-01-16 |
| US5856517A (en) | 1999-01-05 |
| CN1495182A (zh) | 2004-05-12 |
| DE69722003T2 (de) | 2004-04-01 |
| DK0915872T3 (da) | 2003-09-08 |
| CY2483B1 (en) | 2005-06-03 |
| EP0915872B1 (en) | 2003-05-14 |
| CN1151149C (zh) | 2004-05-26 |
| ZA976492B (en) | 1998-01-29 |
| TR199900157T2 (xx) | 1999-04-21 |
| MA24287A1 (fr) | 1998-04-01 |
| AU739742B2 (en) | 2001-10-18 |
| AR008267A1 (es) | 1999-12-29 |
| BR9711605A (pt) | 1999-08-24 |
| AU3769097A (en) | 1998-02-20 |
| US6030994A (en) | 2000-02-29 |
| DE69722003D1 (de) | 2003-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4900055A1 (es) | 3,4-di-indolil pirroles | |
| CO4900054A1 (es) | Pirroles sustituidos | |
| NO20033765D0 (no) | 4-Fenylpiperidinforbindelser | |
| AR023289A1 (es) | COMPUESTOS CON ACTIVIDAD INHIBIDORA DE ENDOPEPTIDASA NEUTRA (NEP), COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE, Y PROCEDIMIENTO PARA SU PREPARACIoN. | |
| CO4970780A1 (es) | Nuevos compuestos heterociclicos de piridazina | |
| AR012781A1 (es) | Alfa-cetoamida inhibidores de 20s proteosoma. | |
| UY27357A1 (es) | Nuevos agentes antidiabéticos . | |
| PA8442101A1 (es) | Pirazoles parasiticidas | |
| CO5031247A1 (es) | Compuestos triciclicos sustituidos | |
| AR016131A1 (es) | -oxazolidinonas triciclicamente substituidas, procedimientos para su preparacion, uso de dichos compuestos y medicamentos. | |
| AR248278A1 (es) | Un procedimiento de preparacion de pteridin-4-(3h)-onas, y el procedimiento de sintesis de los intermediarios de aplicacion en dicho procedimiento. | |
| TR200000025T2 (tr) | Azetidinilpropilpiperidin türevleri, ara bağlarıyla tacikinin antagonistleri olarak kullanımları. | |
| AR241531A1 (es) | Un procedimiento para la preparacion derivados de 2-indolinona, y sus sales farmaceuticamente aceptables. | |
| PA8483901A1 (es) | Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia disminuida | |
| ES8504805A1 (es) | Un procedimiento para la preparacion de imidazobenzodiacepinas | |
| AR240924A2 (es) | "procedimiento para preparar derivados de 1,3-oxazolidin-2-ona y sus sales". | |
| ES2075976T3 (es) | Derivados de aminoacido y su empleo como agentes antiviricos. | |
| CO4960660A1 (es) | Derivados de 5-aroil-pirrol-2-ilmetilareno, composiciones farmaceuticas que las contienen y metodos para la preparacion de estos compuestos | |
| AR241534A1 (es) | Compuestos de 7-(2-(5-amino-1,2,4-tiazol-3-il)-2-alcoxiimino-acetamido)-3-metil-imidazo piridinio o imidazo-pirimidinio-3-cefem-4-carboxilato y sus sales. | |
| ECSP972205A (es) | Pirroles sustituidos | |
| ES2051773T3 (es) | Procedimiento para la obtencion de aralquil-4h,1,2,4-triazil derivados. | |
| ES2140552T3 (es) | Derivados indol como inhibidores de la 5-alfa-reductasa-1. | |
| ES2032377T3 (es) | Procedimiento para la preparacion de nuevos compuestos de piridina sustituidos con radicales basicos. (reserva del art. 167.2 cpe). | |
| PE25195A1 (es) | Sintesis de l-aspartil-d-aminoalcanoil-(s)-o-alquilbencil amida utilizada como endulzante artificial | |
| ES472429A1 (es) | Un procedimiento para la preparacion de compuestos de 4-de-soxi-4-amino-eritromicina a. |